Investors and Media
Press Releases
All Releases
View Summary ZIOPHARM Oncology to Present at the 38th Annual Deutsche Bank Health Care Conference
May 22, 2013
PDF 12.5 KB Add to Briefcase
View Summary ZIOPHARM Announces Presentation of Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 in Advanced Melanoma at ASGCT 16th Annual Meeting
May 16, 2013
PDF 51.0 KB Add to Briefcase
View Summary ZIOPHARM Announces Poster Presentation at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting
May 15, 2013
PDF 49.9 KB Add to Briefcase
View Summary ZIOPHARM Announces First Quarter Financial Results and Key Developments
May 7, 2013
PDF 17.7 KB Add to Briefcase
View Summary ZIOPHARM Presents Preclinical Data Supporting DNA-Based IL-12 Therapy for Breast Cancer
Apr 9, 2013
PDF 14.4 KB Add to Briefcase
View Summary ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
Mar 26, 2013
PDF 15.6 KB Add to Briefcase
View Summary ZIOPHARM Reports Fourth Quarter and Full Year 2012 Financial Results
Mar 18, 2013
PDF 58.1 KB Add to Briefcase
View Summary ZIOPHARM Oncology Initiates Phase 2 Study of Ad-RTS IL-12 and Palifosfamide Combination for Treatment of Advanced Breast Cancer
Mar 11, 2013
PDF 13.9 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the Barclays Global Healthcare Conference
Mar 7, 2013
PDF 12.4 KB Add to Briefcase
View Summary ZIOPHARM Oncology Announces Initiation of Indiana University-Sponsored Phase 2 Study of Palifosfamide in Recurrent and Incurable Germ Cell (Testicular and Ovarian) Tumors
Mar 6, 2013
PDF 60.3 KB Add to Briefcase
View Summary Phase 3 Trial of ZIOPHARM'S Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Events
Feb 12, 2013
PDF 12.9 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 15th Annual BIO CEO & Investor Conference
Feb 6, 2013
PDF 12.7 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference
Jan 3, 2013
PDF 12.7 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Participate in the 2012 Deutsche Bank BioFEST Conference
Nov 28, 2012
PDF 12.4 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 24th Annual Piper Jaffray Healthcare Conference
Nov 20, 2012
PDF 12.7 KB Add to Briefcase
View Summary Independent Data Monitoring Committee Recommends Completion of PICASSO 3 Trial as Conducted for ZIOPHARM's Palifosfamide in First-Line Soft Tissue Sarcoma
Nov 14, 2012
PDF 14.0 KB Add to Briefcase
View Summary ZIOPHARM Announces Third Quarter Financial Results and Key Developments
Nov 8, 2012
PDF 18.5 KB Add to Briefcase
View Summary ZIOPHARM Oncology Presents Systemic, DNA/Cell Plasmid Therapy Showing Long-Term Persistence and Anti-Tumor Effects at EORTC-NCI-AACR Meeting
Nov 7, 2012
PDF 51.4 KB Add to Briefcase
View Summary ZIOPHARM Oncology Announces Compelling Clinical Activity in Phase 1 Study of Ad-RTS IL-12 in Advanced Melanoma and Dosing of First Patient in Phase 2 Study
Oct 25, 2012
PDF 14.3 KB Add to Briefcase
View Summary ZIOPHARM Issues Statement Regarding Misleading Blog
Oct 19, 2012
PDF 8.5 KB Add to Briefcase
Showing 1-20 of 306 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase